INS and type 2 diabetes mellitus: Collectively, the monogenic diabetes phenotypes and the temporary response of type 2 diabetes to SU therapy suggest that multiple processes downstream of mitochondrial metabolism and the KATP channel within the pancreatic beta cell, that regulate the amplification response to glucose or insulin exocytosis itself, is involved in type 2 diabetes [12].